Total Payments
$20,004
2024 Payments
$969.09
Companies
32
Transactions
423
Medicare Patients
5,179
Medicare Billing
$6.2M
Payment Breakdown by Category
Other$9,500 (47.5%)
Food & Beverage$7,652 (38.3%)
Travel$2,674 (13.4%)
Education$178.17 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,500 | 6 | 47.5% |
| Food and Beverage | $7,652 | 407 | 38.3% |
| Travel and Lodging | $2,674 | 5 | 13.4% |
| Education | $178.17 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $13,942 | 74 | $0 (2024) |
| Amgen Inc. | $970.93 | 73 | $0 (2024) |
| Genentech USA, Inc. | $693.76 | 47 | $0 (2023) |
| Janssen Biotech, Inc. | $572.53 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $403.32 | 23 | $0 (2024) |
| PFIZER INC. | $378.85 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $349.68 | 24 | $0 (2024) |
| UCB, Inc. | $323.40 | 16 | $0 (2024) |
| Horizon Pharma plc | $293.93 | 12 | $0 (2018) |
| Lilly USA, LLC | $284.35 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $969.09 | 58 | ABBVIE INC. ($303.30) |
| 2023 | $1,232 | 45 | ABBVIE INC. ($249.08) |
| 2022 | $806.06 | 46 | Amgen Inc. ($125.88) |
| 2021 | $693.60 | 46 | Amgen Inc. ($170.71) |
| 2020 | $448.65 | 27 | Janssen Biotech, Inc. ($115.54) |
| 2019 | $812.18 | 56 | AbbVie, Inc. ($174.78) |
| 2018 | $8,450 | 60 | AbbVie, Inc. ($7,778) |
| 2017 | $6,593 | 85 | AbbVie, Inc. ($5,206) |
All Payment Transactions
423 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: INFLIXIMAB | ||||||
| 10/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Bone Health | ||||||
| 10/11/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: Rheumatology | ||||||
| 10/08/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Bone Health | ||||||
| 08/27/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,307 | 179,233 | $8.4M | $2.1M |
| 2022 | 22 | 1,290 | 98,644 | $5.8M | $1.5M |
| 2021 | 24 | 1,329 | 90,515 | $5.3M | $1.5M |
| 2020 | 25 | 1,253 | 62,922 | $3.7M | $1.2M |
Total Patients
5,179
Total Services
431,314
Medicare Billing
$6.2M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 29 | 2,881 | $111,635 | $47,441 | 42.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 224 | 454 | $151,182 | $39,947 | 26.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 77 | 248 | $124,992 | $25,988 | 20.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 84 | 342 | $87,894 | $17,911 | 20.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 94 | 94 | $47,752 | $11,018 | 23.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 158 | $35,708 | $9,669 | 27.1% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 77 | 299 | $31,096 | $6,782 | 21.8% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 24 | 50 | $20,493 | $4,449 | 21.7% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 41 | 188 | $15,416 | $2,426 | 15.7% |
| 20604 | Aspiration and/or injection of small joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 25 | 38 | $11,328 | $2,374 | 21.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 45 | 172 | $16,354 | $1,766 | 10.8% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 17 | 21 | $3,948 | $811.62 | 20.6% |
| 20551 | Injections of tendon attachment to bone | Office | 2021 | 11 | 22 | $4,531 | $778.61 | 17.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 30 | $4,050 | $740.35 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 121 | 245 | $3,430 | $732.60 | 21.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2021 | 11 | 55 | $1,815 | $438.76 | 24.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 68 | 414 | $5,782 | $414.97 | 7.2% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2021 | 38 | 109 | $1,526 | $360.56 | 23.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2021 | 38 | 116 | $786.38 | $85.60 | 10.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2020 | 44 | 7,161 | $1.2M | $295,923 | 23.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2020 | 25 | 14,150 | $721,650 | $222,643 | 30.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 22 | 5,025 | $499,200 | $213,032 | 42.7% |
| J9312 | Injection, rituximab, 10 mg | Office | 2020 | 21 | 3,000 | $495,000 | $204,250 | 41.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2020 | 13 | 29,200 | $163,200 | $83,520 | 51.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 21 | 1,860 | $65,100 | $29,127 | 44.7% |
About Dr. Diman Lamichhane, MD
Dr. Diman Lamichhane, MD is a Rheumatology healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700067360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diman Lamichhane, MD has received a total of $20,004 in payments from pharmaceutical and medical device companies, with $969.09 received in 2024. These payments were reported across 423 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,500).
As a Medicare-enrolled provider, Lamichhane has provided services to 5,179 Medicare beneficiaries, totaling 431,314 services with total Medicare billing of $6.2M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology, Internal Medicine
- Location Eugene, OR
- Active Since 11/23/2007
- Last Updated 09/27/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1700067360
Products in Payments
- Humira (Biological) $3,467
- Enbrel (Biological) $526.62
- RINVOQ (Biological) $470.25
- Rituxan (Biological) $413.34
- ORENCIA (Biological) $403.32
- XELJANZ (Drug) $305.44
- SIMPONI ARIA (Biological) $293.31
- EVENITY (Biological) $291.60
- Cimzia (Drug) $278.52
- KRYSTEXXA (Biological) $226.32
- Actemra (Biological) $217.25
- KEVZARA SARILUMAB INJECTION (Biological) $198.75
- SKYRIZI (Biological) $198.07
- KRYSTEXXA (Drug) $198.02
- COSENTYX (Biological) $186.78
- TALTZ (Drug) $185.52
- Otezla (Drug) $172.08
- SAPHNELO (Biological) $171.49
- REMICADE (Biological) $157.03
- BENLYSTA (Biological) $126.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Eugene
William Maier, Md, MD
Rheumatology — Payments: $5,266
Rheumatology $5,266
Sidney Cassell, Md, MD
Rheumatology — Payments: $1,818
Rheumatology $1,818
Simona Braun, Md, MD
Rheumatology — Payments: $1,765
Rheumatology $1,765
Sarah Cassell
Rheumatology — Payments: $1,444
Rheumatology $1,444
Hesham Elmergawy, M.d, M.D
Rheumatology — Payments: $879.81
Rheumatology $879.81
Dr. Norman Hudson, Md, MD
Rheumatology
Rheumatology